Intravenous thrombolysis is feasible and safe in multiethnic Asian stroke patients in Singapore.
Sharma
V K
VK
Tsivgoulis
G
G
Tan
J H
JH
Ong
B K C
BK
Chan
B P L
BP
Teoh
H L
HL
D000328:Adult; D000368:Aged; D002543:Cerebral Hemorrhage / Q000139:chemically induced* / Q000517:prevention & control; D004305:Dose-Response Relationship, Drug; D005260:Female; D005343:Fibrinolytic Agents / Q000627:therapeutic use*; D006801:Humans; D007275:Injections, Intravenous; D008297:Male; D008875:Middle Aged; D012307:Risk Factors; D012846:Singapore; D020521:Stroke / Q000188:drug therapy* / Q000208:ethnology; D015912:Thrombolytic Therapy / Q000009:adverse effects*; D010959:Tissue Plasminogen Activator / Q000627:therapeutic use*; D016896:Treatment Outcome
D005343:Fibrinolytic Agents; D010959:Tissue Plasminogen Activator